Oral lichen planus following the administration of vector-based COVID-19 vaccine (Ad26.COV2.S).

Troeltzsch, Matthias; Gogl, Markus; Berndt, Ronald; Troeltzsch, Markus

Troeltzsch, Matthias; Gogl, Markus; Berndt, Ronald; Troeltzsch, Markus.

Troeltzsch M; Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, University Hospital, LMU Munich, Munich, Germany.
Gogl M; Center for Oral, Maxillofacial and Facial Reconstructive Surgery, Ansbach, Germany.
Berndt R; Center for Oral, Maxillofacial and Facial Reconstructive Surgery, Ansbach, Germany.
Troeltzsch M; Department of Pathology, Ansbach General Hospital, Ansbach, Germany.

Oral Dis ; 28 Suppl 2: 2595-2596, 2022 11.

Article in English | MEDLINE | ID: covidwho-2119027

Subject(s)

COVID-19; Lichen Planus, Oral; Humans; COVID-19 Vaccines/adverse effects; Ad26COVS1; COVID-19/prevention & control; Case-Control Studies

Keywords

Ad26.COV2.S; COVID vaccine; COVID-19; oral lichen planus

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lichen Planus, Oral / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: Oral Dis Journal subject: Dentistry Year: 2022 Document Type: Article Affiliation country: Odi.14025

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google